Systemic Immune-Inflammation Index and Long-Term Mortality in Patients with Stroke-Associated Pneumonia
DOI: https://doi.org/10.2147/JIR.S399371
IF: 4.5
2023-04-18
Journal of Inflammation Research
Abstract:Mengdi Xie, 1, &ast Kang Yuan, 2, &ast Xinyi Zhu, 2, &ast Jingjing Chen, 3 Xiaohao Zhang, 4 Yi Xie, 2 Min Wu, 1 Zhaojun Wang, 2 Rui Liu, 2 Xinfeng Liu 1, 2, 5 1 Department of Neurology, Jinling Hospital, Nanjing Medical University, Nanjing, People's Republic of China; 2 Department of Neurology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China; 3 Department of Neurology, Changhai Hospital, Navy Medical University, Shanghai, People's Republic of China; 4 Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, People's Republic of China; 5 Stroke Center & Department of Neurology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xinfeng Liu, Department of Neurology, Jinling Hospital, Nanjing Medical University, No. 305 East Zhongshan Road, Nanjing, Jiangsu Province, 210000, People's Republic of China, Tel +86 2584801861, Fax +86 2584805169, Email Rui Liu, Department of Neurology, Affiliated Jinling Hospital, Medical School of Nanjing University, No. 305 East Zhongshan Road, Nanjing, 210000, Jiangsu Province, People's Republic of China, Tel +86 2584801861, Fax +86 2584805169, Email Background: Systemic immune inflammation has been investigated as a prognostic marker of different diseases. This study is designed to assess the association of systemic immune-inflammation index (SII) with long-term mortality of stroke-associated pneumonia (SAP) patients. Methods: Patients aged ≥ 18 years with SAP were selected from the Nanjing Stroke Registry Program in China. We retrospectively evaluated systemic immune-inflammation response with SII and pneumonia severity with the pneumonia severity index and the confusion, uremia, elevated respiratory rate, hypotension, and aged 65 years or older score. To explore the correlation between SII and mortality in SAP patients, multivariable Cox regressions and competing risk regressions were conducted. Mediation analysis was also performed to assess the role of pneumonia severity. Results: Among 611 patients in the SAP population, death occurred in 164 patients (26.8%) during the median follow-up of 3.0 (1.2– 4.6) years. In multivariate analysis, higher SII scores could predict increased mortality in patients with SAP (adjusted hazard ratio 2.061; 95% confidence interval, 1.256– 3.383; P = 0.004), and the association was mediated by pneumonia severity. Moreover, adding SII to traditional models improved their predictive ability for mortality. Conclusion: Our study displayed that SII was characterized in SAP patients with different prognoses. Elevated SII scores increased the risk of mortality. Further research is required for the clinical practice of the index among SAP patients. Keywords: systemic immune-inflammation index, stroke-associated pneumonia, mortality, China Stroke is the second-leading cause of death and the third-leading cause of death and disability combined globally. 1 Of particular note, the incidence and prevalence of stroke have grown faster in China than in other countries due to the aging of the general population. 2 It is imperative to improve the quality of stroke treatment and the quality of life in stroke patients. Stroke-associated pneumonia (SAP) is one of the most frequent medical complications in patients with stroke, whose incidence varies among different studies. 3–6 Poststroke pneumonia has been proven to be a risk factor for the development of other non-pneumonia complications after acute ischemic stroke (AIS). 7 In addition, SAP is significantly associated with worse prognoses, 5 prolonged hospitalization durations, 8 and increased medical costs. 9 Previous studies have developed several risk scores or machine learning models to predict SAP. 3,4,10–12 Nevertheless, risk factors that influence the outcomes of SAP remain unclear. A study from the UK demonstrates that age, pre-stroke disability, dementia, lung cancer, and previous transient ischemic attack are independently associated with the 6-month mortality of SAP patients. However, laboratory indicators are not significant in this study. 13 Thus, an easy and objective predictor is needed to predict SAP outcomes. Peripheral blood cells are verified to be significantly correlated with outcomes of both stroke and pneumonia. It is -Abstract Truncated-
immunology